ATTOVIA THERAPEUTICS, INC.

Consensus Attovia Therapeutics, Inc.

Stocks

ATTO

US04987L1026

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-10-30 EDT			5-day change	1st Jan Change
15.19 ^USD	-0.52%		+4.76%	-

09-20	Attovia Therapeutics, Inc.(NasdaqGM:ATTO) added to S&P TMI Index	CI
09-16	Attovia Therapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 10:00 AM

Evolution of the Average Target: Attovia Therapeutics, Inc.

Evolution of the Average Target - Attovia Therapeutics, Inc.

Evolution of the Target Price: Attovia Therapeutics, Inc.

Evolution of the Target Price - Attovia Therapeutics, Inc.

Changes in Analyst Recommendations: Attovia Therapeutics, Inc.

3d99d285eaf9b17.zhfKrfMjTMrTmNy6y1Rag2rKGZttuOX9DcKI4ol0Iy4.mjqV_IFmFbC-75bluycj1EeHQ8MoiafNWIbP1-MlRWedcaL7xWZ_oZqpnQ~033db840e11a7f187328484d3c102f79

Analysts' recommendations: Attovia Therapeutics, Inc.

08-31	Attovia Therapeutics Could Serve as Key Player in Immunology, Inflammation, RBC Says	MT
08-31	Morgan Stanley Initiates Coverage on Attovia Therapeutics With Overweight Rating	MT
08-31	Leerink Partners Initiates Attovia Therapeutics at Outperform With $52 Price Target	MT
08-31	RBC Initiates Attovia Therapeutics at Outperform, Speculative Risk With $45 Price Target	MT
08-31	Citigroup Initiates Attovia Therapeutics at Buy With $30 Price Target	MT

More recommendations

Bio Therapeutic Drugs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ATTOVIA THERAPEUTICS, INC.	-	-			+176.36%
	WUXI APPTEC CO., LTD.					+41.6%
	ARGENX SE					+24.9%
	LONZA GROUP AG					+8.71%
	IQVIA HOLDINGS INC.					+12.62%
	BEONE MEDICINES AG					+17.47%
	REVOLUTION MEDICINES, INC.					+36.04%
	GENMAB A/S					+1%
	CELLTRION, INC.					+42.98%
	WUXI BIOLOGICS (CAYMAN) INC.					+33.85%
	Average					+39.55%
	Weighted average by Cap.					+24.58%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

5

Last Close Price

15.27USD

Average target price

42.20USD

Spread / Average Target

+176.36%

High Price Target

52.00USD

Spread / Highest target

+240.54%

Low Price Target

30.00USD

Spread / Lowest Target

+96.46%

Analyst Consensus Detail

Analyst consensus - Attovia Therapeutics, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Attovia Therapeutics, Inc.

Stock Market
Stocks
ATTO Stock
Consensus Attovia Therapeutics, Inc.

As early as today, start finding the best investment opportunities!